Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Consultant & Investment GroupAMM:CICO 73 3-Year EPS without NRI Growth Rate is 28.80% as of Jun. 2026, which is 347% above its 10-year median of 6.45. GuruFocus rates AMM:CICO with a GF Score™ of 73/100 and a GF Value™ of JOD2.05 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 507 Healthcare Providers & Services companies, The Consultant & Investment Group ranks better than 72.58% on this metric.
During the past 12 months, The Consultant & Investment Group's average EPS without NRI Growth Rate was -21.40% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 28.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of The Consultant & Investment Group was 28.80% per year. The lowest was -28.80% per year. And the median was 6.45% per year.
The Consultant & Investment Group (AMM:CICO) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
The Consultant & Investment Group 3-Year EPS without NRI Growth Rate Related Terms
AMM:CICO vs HCA, THC, DVA: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Care Facilities subindustry, The Consultant & Investment Group's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Consultant & Investment Group 3-Year EPS without NRI Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, The Consultant & Investment Group's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where The Consultant & Investment Group's 3-Year EPS without NRI Growth Rate falls into.
The Consultant & Investment Group 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 28.80% mean?
The Consultant & Investment Group (AMM:CICO) has a 3-Year EPS without NRI Growth Rate of 28.80% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for The Consultant & Investment Group and its competitors. This is 347% above median its historical median of 6.45. According to the industry distribution chart, The Consultant & Investment Group ranks #139 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 27.4%.
Is The Consultant & Investment Group's 3-Year EPS without NRI Growth Rate too high?
The Consultant & Investment Group's current 3-Year EPS without NRI Growth Rate of 28.80% is 347% above median its 10-year median of 6.45. The Healthcare Providers & Services industry median 3-Year EPS without NRI Growth Rate is 11.30. The Consultant & Investment Group's value of 28.80% is 154.9% above this industry median. Based on the distribution chart, The Consultant & Investment Group ranks #139 out of 507 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, The Consultant & Investment Group has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Consultant & Investment Group's 3-Year EPS without NRI Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, The Consultant & Investment Group ranks #139 out of 507 companies for 3-Year EPS without NRI Growth Rate. This puts The Consultant & Investment Group in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 11.30. The Consultant & Investment Group's value of 28.80% is 154.9% above this benchmark. While the company's 10-year median is 6.45 vs. the industry median of 11.30, The Consultant & Investment Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EPS without NRI Growth Rate among Healthcare Providers & Services companies is 11.30, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Consultant & Investment Group's current 3-Year EPS without NRI Growth Rate of 28.80% is 154.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for The Consultant & Investment Group and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EPS without NRI Growth Rate is 11.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Consultant & Investment Group's current 3-Year EPS without NRI Growth Rate is 28.80%, which is 347% above median its own 10-year median of 6.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Consultant & Investment Group stock overvalued right now?
Based on GuruFocus' analysis, The Consultant & Investment Group (AMM:CICO) is currently considered Modestly Undervalued. The stock's GF Value™ is JOD2.05, compared to a current price of JOD1.78 — trading 13.2% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 28.80%, which is 347% above median its 10-year median of 6.45 and 154.9% above the Healthcare Providers & Services industry median of 11.30. The Consultant & Investment Group's overall GF Score™ is 73/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For The Consultant & Investment Group (AMM:CICO), the current 3-Year EPS without NRI Growth Rate is 28.80% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Consultant & Investment Group (AMM:CICO) Overvalued in 2026?
Based on GuruFocus' analysis, The Consultant & Investment Group stock appears to be undervalued.
The current stock price of JOD1.78 is trading 13.2% below its estimated GF Value™ of JOD2.05.
GuruFocus considers The Consultant & Investment Group to be Modestly Undervalued.
Key valuation signals for AMM:CICO:
3-Year EPS without NRI Growth Rate: 28.80% (347% above median its 10-year median of 6.45)
GF Value™: JOD2.05 vs. price of JOD1.78 (13.2% below fair value)
Industry Position: 154.9% above the Healthcare Providers & Services median (#139 of 507)
No single metric tells the full story. See the AMM:CICO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Consultant & Investment Group is a Jordan-based company that engages in the healthcare and medical sector. It is engaged in the provision of medical care services. The company generates revenue from medical services and the sale of medicine and medical/ supplies are recognized. The company gains majority of revenue from Jordan. The Group principally operates only in the Hashemite Kingdom of Jordan.
73GF Score
Get the complete analysis for AMM:CICO
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:CICO has been successfully added to your 
